CHARLES SCHWAB INVESTMENT MANAGEMENT INC - VOYAGER THERAPEUTICS INC ownership

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of VOYAGER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$683,341
-29.8%
88,173
+3.7%
0.00%
Q2 2023$973,880
+914.9%
85,055
+583.4%
0.00%
Q1 2023$95,959
+26.4%
12,4460.0%0.00%
Q4 2022$75,921
+2.6%
12,4460.0%0.00%
Q3 2022$74,0000.0%12,4460.0%0.00%
Q2 2022$74,000
-39.3%
12,446
-21.8%
0.00%
Q1 2022$122,000
-74.2%
15,910
-86.1%
0.00%
Q2 2021$472,000
-39.3%
114,256
-30.7%
0.00%
Q1 2021$777,000
-36.0%
164,879
-2.9%
0.00%
Q4 2020$1,215,000
-31.9%
169,890
+1.6%
0.00%
-100.0%
Q3 2020$1,785,000
-15.2%
167,227
+0.3%
0.00%0.0%
Q2 2020$2,104,000
+11.6%
166,678
-19.1%
0.00%0.0%
Q1 2020$1,886,000
-33.9%
206,102
+0.7%
0.00%
-50.0%
Q4 2019$2,854,000
-16.8%
204,587
+2.7%
0.00%0.0%
Q3 2019$3,430,000
-10.0%
199,288
+42.4%
0.00%0.0%
Q2 2019$3,809,000
+58.8%
139,916
+11.7%
0.00%0.0%
Q1 2019$2,398,000
+123.7%
125,269
+9.9%
0.00%
+100.0%
Q4 2018$1,072,000
-51.2%
114,000
-1.7%
0.00%0.0%
Q3 2018$2,195,000
+10.6%
115,987
+14.2%
0.00%0.0%
Q2 2018$1,985,000
+21.8%
101,576
+17.1%
0.00%0.0%
Q1 2018$1,630,000
+27.4%
86,727
+12.6%
0.00%0.0%
Q4 2017$1,279,000
+24.7%
77,038
+54.7%
0.00%0.0%
Q3 2017$1,026,000
+293.1%
49,788
+71.5%
0.00%
Q2 2017$261,000
-31.9%
29,035
+0.4%
0.00%
Q1 2017$383,000
+7.6%
28,921
+3.7%
0.00%
Q4 2016$356,000
+9.9%
27,895
+3.4%
0.00%
Q3 2016$324,000
+12.1%
26,971
+2.6%
0.00%
Q2 2016$289,000
+91.4%
26,281
+52.2%
0.00%
Q1 2016$151,000
-59.5%
17,271
+1.5%
0.00%
-100.0%
Q4 2015$373,00017,0160.00%
Other shareholders
VOYAGER THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 6,391,176$60,077,00050.34%
ARMISTICE CAPITAL, LLC 2,836,000$26,658,0002.02%
Casdin Capital, LLC 1,128,075$10,604,0001.81%
BB BIOTECH AG 2,865,841$26,939,0000.86%
HIGHLINE CAPITAL MANAGEMENT, L.P. 1,284,697$12,076,0000.81%
Aevitas Wealth Management, Inc. 48,300$454,0000.46%
GREAT POINT PARTNERS LLC 365,132$3,432,0000.43%
Patriot Financial Group Insurance Agency, LLC 61,320$576,0000.38%
HARBOURVEST PARTNERS LLC 72,726$684,0000.32%
Birchview Capital, LP 33,000$310,0000.29%
View complete list of VOYAGER THERAPEUTICS INC shareholders